Skip to content
Home/Companies/Biotech/Forward Pharma

Forward Pharma

Biotech·Denmark·Exited 2014·Held 8yr
Entry
2006
Hold
8yr
Exit
2014

Who owns Forward Pharma?

Forward Pharma is a Danish Biotech company, formerly owned by Nordic Biotech Advisors, exited in 2014 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Biotech Advisors
Investor
Nordic Biotech Advisors
Nordic Biotech K/S · 2002 · Life Sciences VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2014

More from Nordic Biotech K/S

Other portfolio companies in the same fund.

Curalogic
Exited 2006
BiotechDenmark· 2004
Gastrotech Pharma
Active
BiotechDenmark· 2003
Osteologix
Exited 2006
BiotechDenmark· 2003
LifeCycle Pharma
Exited 2006
PharmaDenmark· 2002

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Forward Pharma?

Forward Pharma was formerly owned by Nordic Biotech Advisors, exited in 2014. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue